Whitehawk (WHWK) Director Anupam Dalal Receives 1.28M-Share Award

What Happened
Anupam Dalal, a director of Whitehawk Therapeutics (WHWK), received a large equity award and a related derivative grant. On 2026-05-14 Dalal was granted 1,275,510 shares at $3.92 per share (total value reported as $4,999,999). On 2026-06-12 Dalal received an additional 38,040-share derivative award (reported at $0.00 price), which is subject to vesting conditions. These transactions are awards/grants (code A) — they are acquisitions of company equity rather than open-market purchases or sales.

Key Details

• Transaction dates and prices:
  • 2026-05-14: 1,275,510 shares @ $3.92 — reported value $4,999,999 (award).
  • 2026-06-12: 38,040 shares @ $0.00 — reported as a derivative award (subject to vesting).
• Vesting note (footnote): The 38,040-share grant (Date of Grant June 12, 2026) vests 100% on the earlier of the one‑year anniversary of the grant (June 12, 2027) or the day before the next annual stockholder meeting, provided Dalal remains a Service Provider.
• Shares reported as beneficially owned (per filing footnote): 3,538,288 shares held by Acuta Capital Fund, LP and 1,147,624 shares held by Acuta Opportunity Fund, LP (total 4,685,912). Dalal is CIO and Managing Member of Acuta Partners and has voting/investment authority over those fund holdings; the filing disclaims direct beneficial ownership except to the extent of pecuniary interest.
• Filing timeliness: The Form 4 was filed 2026-07-30 for a 2026-05-14 transaction (filed late — ~77 days after the primary transaction). Late filings reduce public transparency but do not by themselves imply wrongdoing.

Context

• These are equity awards (not open‑market purchases or sales). Awards and deferred/derivative grants are common for directors and can be subject to vesting, forfeiture, or other conditions; they do not necessarily indicate the insider’s view of the stock’s near‑term prospects.
• The 38,040-share item is a derivative/vested-later award (not an immediate free share), so it may not result in immediate ownership unless vesting conditions are met.
• The reported fund holdings indicate this filing reflects institutional/control relationships (Dalal’s authority over fund positions) rather than solely personal trading.